Page last updated: 2024-08-21

vancomycin and abt 492

vancomycin has been researched along with abt 492 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cammarata, SK; Duffy, E; Henry, E; Kingsley, J; Lawrence, LE; Mehra, P; Pullman, J1
Cammarata, S; Farley, B; Gardovskis, J; Lawrence, L; Ling, R; Pullman, J; Quintas, M; Sun, E1
Cammarata, S; Cruz-Saldariagga, M; Lawrence, L; Liang, S; McManus, A; O'Riordan, W; Poromanski, I; Quintas, M; Teras, J1
Miller, LG1
Pawlak, JM; Saravolatz, LD; Wegner, C1

Trials

3 trial(s) available for vancomycin and abt 492

ArticleYear
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:3

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Linezolid; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult

2016
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.
    The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aztreonam; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Humans; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult

2017
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 08-16, Volume: 67, Issue:5

    Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Aztreonam; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult

2018

Other Studies

2 other study(ies) available for vancomycin and abt 492

ArticleYear
Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 03-19, Volume: 68, Issue:7

    Topics: Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Fluoroquinolones; Humans; Infections; Specialization; Vancomycin

2019
Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    The Journal of antimicrobial chemotherapy, 2020, 09-01, Volume: 75, Issue:9

    Topics: Anti-Bacterial Agents; Daptomycin; Fluoroquinolones; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2020